These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25794600)

  • 1. Pragmatic randomized trials in drug development pose new ethical questions: a systematic review.
    Kalkman S; van Thiel GJ; Grobbee DE; van Delden JJ
    Drug Discov Today; 2015 Jul; 20(7):856-62. PubMed ID: 25794600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stakeholders' views on the ethical challenges of pragmatic trials investigating pharmaceutical drugs.
    Kalkman S; van Thiel GJ; Grobbee DE; Meinecke AK; Zuidgeest MG; van Delden JJ;
    Trials; 2016 Aug; 17(1):419. PubMed ID: 27550379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders.
    Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M;
    Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethical Considerations in Conducting Pragmatic Trials in Oncology.
    Hammer MJ
    Oncol Nurs Forum; 2017 Sep; 44(5):537-539. PubMed ID: 28820523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethics and regulatory complexities for pragmatic clinical trials.
    Sugarman J; Califf RM
    JAMA; 2014 Jun; 311(23):2381-2. PubMed ID: 24810723
    [No Abstract]   [Full Text] [Related]  

  • 6. Cluster over individual randomization: are study design choices appropriately justified? Review of a random sample of trials.
    Taljaard M; Goldstein CE; Giraudeau B; Nicholls SG; Carroll K; Hey SP; Brehaut JC; Jairath V; London AJ; Eldridge SM; Grimshaw JM; Fergusson DA; Weijer C
    Clin Trials; 2020 Jun; 17(3):253-263. PubMed ID: 32367741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.
    Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA
    Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stakeholder views regarding ethical issues in the design and conduct of pragmatic trials: study protocol.
    Nicholls SG; Carroll K; Brehaut J; Weijer C; Hey SP; Goldstein CE; Zwarenstein M; Graham ID; McKenzie JE; McIntyre L; Jairath V; Campbell MK; Grimshaw JM; Fergusson DA; Taljaard M
    BMC Med Ethics; 2018 Nov; 19(1):90. PubMed ID: 30458809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical and Regulatory Issues for Embedded Pragmatic Trials Involving People Living with Dementia.
    Largent EA; Hey SP; Harkins K; Hoffman AK; Joffe S; Lima JC; London AJ; Karlawish J
    J Am Geriatr Soc; 2020 Jul; 68 Suppl 2(Suppl 2):S37-S42. PubMed ID: 32589273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical complexities in standard of care randomized trials: A case study of morning versus nighttime dosing of blood pressure drugs.
    Kim SY; Miller FG
    Clin Trials; 2015 Dec; 12(6):557-63. PubMed ID: 26400874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial.
    Marquis-Gravel G; Robertson H; Jones WS; Riley D; Ford DE; Crenshaw D; Joosten YA; Rudov L; Hernandez AF; Hess R
    Trials; 2021 Jan; 22(1):90. PubMed ID: 33494785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethics and practice of Trials within Cohorts: An emerging pragmatic trial design.
    Kim SY; Flory J; Relton C
    Clin Trials; 2018 Feb; 15(1):9-16. PubMed ID: 29224380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Series: Pragmatic trials and real world evidence: Paper 4. Informed consent.
    Kalkman S; van Thiel GJMW; Zuidgeest MGP; Goetz I; Pfeiffer BM; Grobbee DE; van Delden JJM;
    J Clin Epidemiol; 2017 Sep; 89():181-187. PubMed ID: 28502809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical Acceptability of Postrandomization Consent in Pragmatic Clinical Trials.
    Miller DG; Kim SYH; Li X; Dickert NW; Flory J; Runge CP; Relton C
    JAMA Netw Open; 2018 Dec; 1(8):e186149. PubMed ID: 30646316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ethical justification for inclusion of neonates in pragmatic randomized clinical trials for emergency newborn care.
    Kaye DK
    BMC Pediatr; 2019 Jul; 19(1):218. PubMed ID: 31266486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethics of Informed Consent for Pragmatic Trials with New Interventions.
    Kalkman S; Kim SYH; van Thiel GJMW; Grobbee DE; van Delden JJM
    Value Health; 2017; 20(7):902-908. PubMed ID: 28712619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A limited number of medicines pragmatic trials had potential for waived informed consent following the 2016 CIOMS ethical guidelines.
    Dal-Ré R; Avendaño-Solà C; de Boer A; James SK; Rosendaal FR; Stephens R; Ioannidis JPA
    J Clin Epidemiol; 2019 Oct; 114():60-71. PubMed ID: 31212001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurring and Emerging Ethical Issues in Pragmatic Clinical Trials.
    Propes C; O'Rourke PP; Morain SR
    Circ Cardiovasc Qual Outcomes; 2024 Jul; 17(7):e010847. PubMed ID: 39012931
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration and pragmatic clinical trials of marketed medical products.
    Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE
    Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A framework for analysis of research risks and benefits to participants in standard of care pragmatic clinical trials.
    Chen SC; Kim SY
    Clin Trials; 2016 Dec; 13(6):605-611. PubMed ID: 27365010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.